Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease reversal » increases reversal (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 61 - 80 results of 19,733 for search '(( significantly ((better decrease) OR (mean decrease)) ) OR ( significant decrease reversal ))', query time: 0.80s Refine Results
  1. 61
    Fig 2 -

    Fig 2 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 62
    Fig 1 -

    Fig 1 - by Hassan Mehmood (9574947)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 63
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 64
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 66
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 67
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 68
    S1 Data -

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Clinical course of patient no.

    Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 70
    Socio-demographic and medical characteristics of patients with liver cancer.

    Socio-demographic and medical characteristics of patients with liver cancer. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific.

    Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023.

    Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023.

    Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023.

    Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023.

    Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023.

    Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023).

    Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). by Ayana Ablayeva (22103708)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 80
    Socio-demographic characteristics of women in study sample (means except as noted).

    Socio-demographic characteristics of women in study sample (means except as noted). by Chelsea Ducille (21540080)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: